secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aurinia Pharmaceuticals Inc. (AUPH)
CIK:        0001600620
Form:       8-K
Filed at:   2022-10-21T23:59:59+00:00
Accession:  0001628280-22-026779
Event type: leadership
Sentiment:  negative
Materiality: 0.75
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Aurinia EVP Research and CMO depart effective Oct 31, 2022
----------------------------------------------------------

- Robert Huizinga, EVP Research, and Neil Solomons, CMO, mutually agreed to leave Aurinia.
- Huizinga severance: $575,015 base pay, $159,311 vacation, $191,672 bonus target (50% of 2022).
- Solomons severance: $698,230 base pay, $192,157 vacation, $232,743 bonus target (50% of 2022).
- Both departures effective Oct 31, 2022; benefits coverage for up to 18 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1600620/000162828022026779/0001628280-22-026779-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1600620/000162828022026779/auph-20221017.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-026779

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer